Palmitoylethanolamide (PEA) is an endogenous fatty acid amide produced naturally in the body in response to injury and stress. It is found in lipid extracts of foods and plants such as egg yolk, peanuts and soybeans, as well as produced naturally in the body.

PEA also influences the endocannabinoid system, thereby considered a safe and clinically-proven alternative to CBD.

Levagen is self-affirmed GRAS and is manufactured in cGMP facilities, further substantiating its quality and safety.

PEA is lipophilic (fat-loving) in nature, therefore has challenges with absorption and has limited format options (i.e. restricted to capsules and tablets). This limits brands and consumers to reap the full-benefits of this unique ingredient.

Gencor have developed Levagen+^®, a cold-water dispersible version of PEA powered by LipiSperse® delivery technology. This award-winning technology helps increase bioavailability and functionality of PEA for food and beverage applications.

PEA is lipophilic (fat-loving) in nature, therefore has challenges with absorption and has limited format options (i.e. restricted to capsules and tablets). This limits brands and consumers to reap the full-benefits of this unique ingredient.

Gencor have developed Levagen+^®, a cold-water dispersible version of PEA powered by LipiSperse^® delivery technology. This award-winning technology helps increase bioavailability and functionality of PEA for food and beverage applications.

Existing literature demonstrates PEA's ability to boost the immune system and provide symptomatic relief of flu symptoms. This is done via numerous pathways, such as the activation of PPAR-a and inhibiting mast cell degranulation.Learn more about PEA's immune-boosting mechanisms, make sure to download the Levagen+^® Immune Health White Paper below.